Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation

Virology

Volumn 357, Issue 1, 2007, Pages 54-67

  Weinberg, Jason B ^a   Jensen, Daniel R ^a   Gralinski, Lisa E ^b   Lake, Amy R ^a   Stempfle, Gregory S ^a   Spindler, Katherine R ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Brain; Chemokine; Inflammation; Lung

Indexed keywords

CHEMOKINE; E1A PROTEIN; MUTANT PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; ADENOVIRUS 1; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE EXPRESSION; INOCULATION; LUNG; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NOSE; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADENOVIRUS E1A PROTEINS; ANIMALS; ANTIGENS, VIRAL; BRAIN; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CHEMOKINES; GENE EXPRESSION; INFLAMMATION; LUNG; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; RESPIRATORY TRACT INFECTIONS; VIRAL LOAD; VIRUS REPLICATION;

ADENOVIRIDAE; MURINE ADENOVIRUS 1;

EID: 33751545601     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.08.013     Document Type: Article

References (72)

1. Ackrill A.M., Foster G.R., Laxton C.D., Flavell D.M., Stark G.R., and Kerr I.M. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19 (1991) 4387-4393
2. Ball A.O., Williams M.E., and Spindler K.R. Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function. J. Virol. 62 (1988) 3947-3957
3. Ball A.O., Beard C.W., Redick S.D., and Spindler K.R. Genome organization of mouse adenovirus type 1 early region 1: a novel transcription map. Virology 170 (1989) 523-536
4. Bangari D.S., and Mittal S.K. Development of nonhuman adenoviruses as vaccine vectors. Vaccine 24 (2006) 849-862
5. Bonville C.A., Rosenberg H.F., and Domachowske J.B. Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr. Allergy Immunol. 10 (1999) 39-44
6. Cadillac J.M., Sigler R.E., Weinberg J.B., Lutzke M.L., and Rochford R. Gammaherpesvirus-induced lung pathology is altered in the absence of macrophages. Lung 183 (2005) 239-251
7. Cauthen A.N., and Spindler K.R. Construction of mouse adenovirus type 1 mutants. In: Wold W.S.M. (Ed). Adenovirus Methods and Protocols (1999), Humana Press, Totowa, NJ 85-103
8. Charles P.C., Guida J.D., Brosnan C.F., and Horwitz M.S. Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice. Virology 245 (1998) 216-228
9. Charles P.C., Chen X., Horwitz M.S., and Brosnan C.F. Differential chemokine induction by the mouse adenovirus type-1 in the central nervous system of susceptible and resistant strains of mice. J. NeuroVirol. 5 (1999) 55-64
10. Charles P.C., Weber K.S., Cipriani B., and Brosnan C.F. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J. Neuroimmunol. (1999) 100
11. Dawson T.C., Beck M.A., Kuziel W.A., Henderson F., and Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156 (2000) 1951-1959
12. Domachowske J.B., Bonville C.A., Gao J.L., Murphy P.M., Easton A.J., and Rosenberg H.F. MIP-1 alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. Cell. Immunol. 206 (2000) 1-6
13. Elliott W.M., Hayashi S., and Hogg J.C. Immunodetection of adenoviral E1A proteins in human lung tissue. Am. J. Respir. Cell Mol. Biol. 12 (1995) 642-648
14. Fang L., and Spindler K.R. E1A-CR3 interaction-dependent and -independent functions of mSur2 in viral replication of early region 1A mutants of mouse adenovirus type 1. J. Virol. 79 (2005) 3267-3276
15. Fang L., Stevens J.L., Berk A.J., and Spindler K.R. Requirement of Sur2 for efficient replication of mouse adenovirus type 1. J. Virol. 78 (2004) 12888-12900
16. Gottlieb K., and Villarreal L.P. The distribution and kinetics of polyomavirus in lungs of intranasally infected newborn mice. Virology 266 (2000) 52-65
17. Guida J.D., Fejer G., Pirofski L.A., Brosnan C.F., and Horwitz M.S. Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J. Virol. 69 (1995) 7674-7681
18. Gutch M.J., and Reich N.C. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7913-7917
19. Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., and Patrick C.C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 23 (1999) 277-282
20. Harrod K.S., Mounday A.D., Stripp B.R., and Whitsett J.A. Clara cell secretory protein decreases lung inflammation after acute virus infection. Am. J. Physiol. 275 (1998) L924-L930
21. Higashimoto Y., Elliott W.M., Behzad A.R., Sedgwick E.G., Takei T., Hogg J.C., and Hayashi S. Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 166 (2002) 200-207
22. + T cells from young and old mice. J. Immunol. 150 (1993) 2614-3602
23. Hogg J.C. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am. J. Respir. Crit. Care Med. 164 (2001) S71-S75
24. Hogaboam C.M., Steinhauser M.L., Schock H., Lukacs N., Strieter R.M., Standiford T., and Kunkel S.L. Therapeutic effects of nitric oxide inhibition during experimental fecal peritonitis: role of interleukin-10 and monocyte chemoattractant protein 1. Infect. Immun. 66 (1998) 650-655
25. Horwitz M.S. Adenoviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology vol. 2 (2001), Lippincott Williams and Wilkins, Philadelphia 2301-2327
26. Kajon A.E., and Spindler K.R. Mouse adenovirus type 1 replication in vitro is resistant to interferon. Virology 274 (2000) 213-219
27. Kajon A.E., Brown C.C., and Spindler K.R. Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J. Virol. 72 (1998) 1219-1223
28. Kajon A.E., Gigliotti A.P., and Harrod K.S. Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract. J. Med. Virol. 71 (2003) 233-244
29. Kalvakolanu D.V., Bandyopadhyay S.K., Harter M.L., and Sen G.C. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7459-7463
30. Kaufmann A., Salentin R., Meyer R.G., Bussfeld D., Pauligk C., Fesq H., Hofmann P., Nain M., Gemsa D., and Sprenger H. Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology 204 (2001) 603-613
31. Keicho N., Elliott W.M., Hogg J.C., and Hayashi S. Adenovirus E1A upregulates interleukin-8 expression induced by endotoxin in pulmonary epithelial cells. Am. J. Physiol. 272 (1997) L1046-L1052
32. Kleinberger T., and Shenk T. Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription. J. Virol. 67 (1993) 7556-7560
33. Konno S., Grindle K.A., Lee W.M., Schroth M.K., Mosser A.G., Brockman-Schneider R.A., Busse W.W., and Gern J.E. Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26 (2002) 594-601
34. Kring S.C., King C.S., and Spindler K.R. Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred Swiss mice. J. Virol. 69 (1995) 8084-8088
35. Leonard G.T., and Sen G.C. Effects of adenovirus E1A protein on interferon-signaling. Virology 224 (1996) 25-33
36. Liu Q., and Muruve D.A. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10 (2003) 935-940
37. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 (1998) 436-445
38. Macek V., Sorli J., Kopriva S., and Marin J. Persistent adenoviral infection and chronic airway obstruction in children. Am. J. Respir. Crit. Care Med. 150 (1994) 7-10
39. Matsuse T., Hayashi S., Kuwano K., Keunecke H., Jefferies W.A., and Hogg J.C. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am. Rev. Respir. Dis. 146 (1992) 177-184
40. Mbawuike I.N., and Herscowitz H.B. MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J. Leukocyte Biol. 46 (1989) 119-127
41. Miller A.L., Bowlin T.L., and Lukacs N.W. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J. Infect. Dis. 189 (2004) 1419-1430
42. Miyazato A., Kawakami K., Iwakura Y., and Saito A. Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1. Clin. Exp. Immunol. 120 (2000) 113-124
43. Mizuguchi H., and Hayakawa T. Targeted adenovirus vectors. Hum. Gene Ther. 15 (2004) 1034-1044
44. Moore M.L., Brown C.C., and Spindler K.R. T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis. J. Virol. 77 (2003) 10060-10070
45. Moore M.L., McKissic E.L., Brown C.C., Wilkinson J.E., and Spindler K.R. Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. J. Virol. 78 (2004) 5584-5590
46. Muller U., Roberts M.P., Engel D.A., Doerfler W., and Shenk T. Induction of transcription factor AP-1 by adenovirus E1A protein and cAMP. Genes Dev. 3 (1989) 1991-2002
47. Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther. 16 (2005) 1016-1027
48. Ransohoff R.M., Wei T., Pavelko K.D., Lee J.C., Murray P.D., and Rodriguez M. Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence. J. Virol. 76 (2002) 2217-2224
49. Reich N., Pine R., Levy D., and Darnell Jr. J.E. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J. Virol. 62 (1988) 114-119
50. Rochford R., Lutzke M.L., Alfinito R.S., Clavo A., and Cardin R.D. Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice. J. Virol. 75 (2001) 4955-4963
51. Roebuck K.A., Carpenter L.R., Lakshminarayanan V., Page S.M., Moy J.N., and Thomas L.L. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J. Leukocyte Biol. 65 (1999) 291-298
52. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., and Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177 (2000) 195-203
53. Schmitz M.L., Indorf A., Limbourg F.P., Stadtler H., Traenckner E.B., and Baeuerle P.A. The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K. Mol. Cell. Biol. 16 (1996) 4052-4063
54. Sellner J., Dvorak F., Zhou Y., Haas J., Kehm R., Wildemann B., and Meyding-Lamade U. Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis. Neurosci. Lett. 374 (2005) 197-202
55. Shin H.S., Drysdale B.E., Shin M.L., Noble P.W., Fisher S.N., and Paznekas W.A. Definition of a lipopolysaccharide-responsive element in the 5′-flanking regions of MuRantes and crg-2. Mol. Cell. Biol. 14 (1994) 2914-2925
56. Smith K., and Spindler K.R. Murine adenovirus. In: Ahmed R., and Chen I. (Eds). Persistent Viral Infections (1999), John Wiley and Sons, Ltd 477-484
57. Smith K., Ying B., Ball A.O., Beard C.W., and Spindler K.R. Interaction of mouse adenovirus type 1 early region 1A protein with cellular proteins pRb and p107. Virology 224 (1996) 184-197
58. Smith K., Brown C.C., and Spindler K.R. The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice. J. Virol. 72 (1998) 5699-5706
59. Spindler K.R., Fang L., Moore M.L., Hirsch G.N., Brown C.C., and Kajon A. SJL/J mice are highly susceptible to infection by mouse adenovirus type 1. J. Virol. 75 (2001) 12039-12046
60. Stoner G.D., Kikkawa Y., Kniazeff A.J., Miyai K., and Wagner R.M. Clonal isolation of epithelial cells from mouse lung adenoma. Cancer Res. 35 (1975) 2177-2185
61. Tripp R.A., Jones L., and Anderson L.J. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J. Virol. 74 (2000) 6227-6229
62. Veckman V., Osterlund P., Fagerlund R., Melen K., Matikainen S., and Julkunen I. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 345 (2006) 96-104
63. Vitalis T.Z., Kern I., Croome A., Behzad H., Hayashi S., and Hogg J.C. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur. Respir. J. 11 (1998) 664-669
64. Walley K.R., Lukacs N.W., Standiford T.J., Strieter R.M., and Kunkel S.L. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect. Immun. 65 (1997) 3847-3851
65. Walls T., Shankar A.G., and Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet, Infect. Dis. 3 (2003) 79-86
66. Wareing M.D., Lyon A.B., Lu B., Gerard C., and Sarawar S.R. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukocyte Biol. 76 (2004) 886-895
67. Weinberg J.B., Lutzke M.L., Efstathiou S., Kunkel S., and Rochford R. Elevated chemokine responses are maintained in lungs after clearance of viral infection. J. Virol. 76 (2002) 10518-10523
68. Weinberg J.B., Stempfle G.S., Wilkinson J.E., Younger J.G., and Spindler K.R. Acute respiratory infection with mouse adenovirus type 1. Virology 340 (2005) 245-254
69. Wickremasinghe M.I., Thomas L.H., O'Kane C.M., Uddin J., and Friedland J.S. Transcriptional mechanisms regulating alveolar epithelial cell-specific CCL5 secretion in pulmonary tuberculosis. J. Biol. Chem. 279 (2004) 27199-27210
70. Yamada K., Elliott W.M., Hayashi S., Brattsand R., Roberts C., Vitalis T.Z., and Hogg J.C. Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J. Allergy Clin. Immunol. 106 (2000) 844-851
71. Young L.S., Searle P.F., Onion D., and Mautner V. Viral gene therapy strategies: from basic science to clinical application. J. Pathol. 208 (2006) 299-318
72. Zhou J., Stohlman S.A., Hinton D.R., and Marten N.W. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol. 170 (2003) 3331-3336